Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.38 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17679177 | 1.00 | TDP1 (0.46) | TDP1SMN1; SMN2SLC22A6CYP1A2TP53 | |
| SCHEMBL16453428 | 1.00 | TDP1 (0.46) | TDP1SMN1; SMN2SLC22A6CYP1A2TP53 | |
| SCHEMBL6738773 | 0.97 | TDP1 (0.43) | TDP1SMN1; SMN2SLC22A6CYP1A2TP53 | |
| SCHEMBL2346353 | 0.84 | TDP1 (0.42) | TDP1SMN1; SMN2SLC22A6CYP1A2TP53 | |
| SCHEMBL14423824 | 0.82 | TDP1 (0.40) | TDP1SMN1; SMN2SLC22A6CYP1A2TP53 | |
| SCHEMBL5077944 | 0.82 | SLC22A6 (0.50) | TDP1SMN1; SMN2SLC22A6CYP1A2CACNA2D1 | |
| SCHEMBL304303 | 0.82 | SLC22A6 (0.50) | TDP1SMN1; SMN2SLC22A6CYP1A2CACNA2D1 | |
| SCHEMBL2348507 | 0.81 | SLC22A6 (0.39) | TDP1SMN1; SMN2SLC22A6CACNA2D1CACNB3 | |
| SCHEMBL2348670 | 0.81 | ALDH1A1 (0.50) | TDP1CYP1A2TP53 | |
| SCHEMBL25397374 | 0.78 | TDP1 (0.46) | TDP1SMN1; SMN2SLC22A6CYP1A2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240051212-A1 | IMPROVED POLYESTER COMPOSITION FOR EXTRUSION BLOW MOLDED CONTAINERS | AURIGA POLYMERS INC (US) | 2024-02-15 | — | — | US | claimed |
| CN-117062894-A | Coolant with improved temperature stability | 巴斯夫欧洲公司 | 2023-11-14 | — | — | CN | claimed |
| EP-4267651-A1 | IMPROVED POLYESTER COMPOSITION FOR EXTRUSION BLOW MOLDED CONTAINERS | Auriga Polymers, Inc. (US) | 2023-11-01 | — | — | EP | claimed |
| CN-116635449-A | Improved polyester compositions for extrusion blow molded containers | 奥里格聚合物股份有限公司 | 2023-08-22 | — | — | CN | claimed |
| WO-2023114069-A1 | IMPROVED POLYESTER COMPOSITION FOR EXTRUSION BLOW MOLDED CONTAINERS | AURIGA POLYMERS, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| WO-2022140183-A1 | IMPROVED POLYESTER COMPOSITION FOR EXTRUSION BLOW MOLDED CONTAINERS | AURIGA POLYMERS, INC. (US) | 2022-06-30 | — | — | WO | claimed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | claimed |
| CN-110643032-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-110643032-A | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2020-01-03 | — | — | CN | claimed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | claimed |
| CN-104530417-B | A kind of multiple functionalized H types polyethyleneglycol derivative and preparation method thereof | 厦门赛诺邦格生物科技股份有限公司 | 2017-09-08 | — | — | CN | claimed |
| CN-105980489-A | Graffiti removal compositions and the use thereof | 加迪特解决方案有限公司 | 2016-09-28 | — | — | CN | claimed |
| EP-2325228-A1 | An aliphatic-aromatic copolyster, the preparation method and the use thereof | Zhejiang Hangzhou Xinfu Pharmaceutical Co. Ltd (CN) | 2011-05-25 | — | — | EP | claimed |
| EP-1062270-A1 | LIGHT AND THERMALLY STABLE POLYAMIDE | BASF CORPORATION (US) | 2000-12-27 | — | — | EP | claimed |
| WO-1999046323-A1 | LIGHT AND THERMALLY STABLE POLYAMIDE | BASF CORPORATION (US) | 1999-09-16 | — | — | WO | claimed |
| CN-122095025-A | Polyamide composition and molded article | — | 2026-05-26 | — | — | CN | disclosed |
| CN-111793331-B | Biodegradable in-situ nanocomposite and preparation method and application thereof | 浙江恒逸石化研究院有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-4101528-A | FLAME RETARDANT | AVTEX FIBERS INC. (US) | 1978-07-18 | — | — | US | disclosed |
| US-4059546-A | Textile fiber blend comprising cellulosic fibers and ethylene 2,6-naphthalene dicarboxylate-halogenated comonomers copolyester fibers | AVTEX FIBERS INC. (US) | 1977-11-22 | — | — | US | disclosed |
| US-4037112-A | Apparatus for crosslinking ultraviolet light curable coatings | PPG INDUSTRIES, INC. (US) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | TDP1 4223/4885SMN1; SMN2 3017/4885SLC22A6 4107/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | TDP1 4223/4885SMN1; SMN2 3017/4885SLC22A6 4107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.